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Abstract
Purpose The pressure on healthcare budgets remains high, partially due to the ageing population. Economic evaluation can 
be a helpful tool to inform resource allocation in publicly financed systems. Such evaluations frequently use health-related 
outcome measures. However, in areas such as care of older people, improving health outcomes is not necessarily the main 
focus of care interventions and broader outcome measures, including outcomes for those providing informal care, may be 
preferred when evaluating such interventions. This paper validates a recently introduced well-being measure, the ICECAP-
O, in a population of informal carers for people with dementia from eight European countries.
Methods Convergent and discriminant validity tests were performed to validate the ICECAP-O using data obtained in a 
sample of 451 respondents from Germany, Ireland, Italy, the Netherlands, Norway, Portugal, Sweden and the UK. These 
respondents completed a number of standardized questionnaires within the framework of the Actifcare project.
Results The ICECAP-O performed well among informal carers, in terms of both convergent and discriminant validity. In 
the multivariate analysis, it was found to be significantly associated with the age of the person with dementia, EQ-5D-5L 
health problem index of the person with dementia, carer–patient relationship, care recipient CDR, carer LSNS Score, the 
PAI score, and Perseverance Time.
Conclusion The ICECAP-O appears to be a valid measure of well-being in informal carers for people with dementia. The 
ICECAP-O may therefore be useful as an outcome measure in economic evaluations of interventions aimed at such informal 
carers, when these aim to improve well-being beyond health.
Keywords Construct validity · ICECAP-O · Informal care · Dementia · Well-being
Introduction
Dementia is highly prevalent in today’s society. It was esti-
mated that worldwide 50 million people lived with demen-
tia in 2018, and with the ageing population this number is 
expected to increase to 82 million by 2030 and further to 152 
million by 2050 [1]. With these increasing numbers comes 
an increase in the magnitude of care required. Family mem-
bers, who are most often elderly spouses, siblings or friends, 
are frequently the ones to provide (part of) this care [2]. 
These informal carers may be unprepared for the physical 
and emotional demands that caring entails and many carers 
experience considerable strain and well-being losses due to 
their caregiving tasks [3, 4].
At the same time, governments struggle with the rising 
demand for care of people with dementia, those with other 
(chronic) diseases, and their carers, and with limited health 
care resources. Regarding decisions for optimal spending, 
economic evaluation is a useful decision-making aid. It is 
increasingly applied in many Western healthcare systems. 
Usually in economic evaluations, health-related quality 
of life (HrQoL) is used to measure intervention benefits. 
However, in areas such as mental health and care of older 
people, improving health outcomes is not necessarily the 
main focus of care interventions [5, 6]. Broader outcome 
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measures, which go ‘beyond health’ [7], capturing the effects 
of interventions in terms of well-being, for both patients and 
carers, may be more appropriate to capture relevant benefits 
of such interventions.
Several well-being measures have recently been devel-
oped, broadening the evaluative scope beyond health in dif-
ferent ways. Some of these have focused on context-specific 
elements of well-being beyond health, such as care-related 
quality of life in carers [8, 9] or social care-use-related well-
being [10]. Analogous with measuring disease-specific qual-
ity of life rather than generic health-related quality of life, 
context-specific measures may be more sensitive to specific 
changes, but this comes at the expense of comparability 
across situations and populations. Generic measures of 
well-being in principle allow comparisons, across interven-
tions, diseases and situations. The ICECAP-O, a capability 
well-being measure for older people, is such a generic well-
being measure [11], which is increasingly used. Capabil-
ity in this context refers to the extent to which a person is 
able to function in a particular way, whether or not he or 
she chooses to do so [11]. The ICECAP-O consists of five 
important general capability well-being dimensions: attach-
ment, security, role, enjoyment and control, and has four 
answering levels per domain. Values for the states described 
with the instrument were derived from a sample of older 
people in England, using best–worst scaling [12]. ICECAP-
O questionnaires and further information can be found on 
the website: www.birmi ngham .ac.uk/resea rch/activ ity/mds/
proje cts/HaPS/HE/ICECA P/ICECA P-O.
As a generic well-being measure, the ICECAP-O is well 
suited for economic evaluation of care interventions in 
elderly populations, especially those who are suffering from 
chronic diseases [13]. Given the generic nature of the instru-
ment, it may be suitable to measure well-being not only in 
patients but also in informal carers. Using the ICECAP-O 
to measure well-being in both patients and their informal 
carers would facilitate comparisons and aggregation of out-
comes within the same economic evaluation. This is also 
relevant for a scenario in which two interventions are being 
compared, and one of these interventions impacts informal 
carers. Without a comparable outcome between patients 
and informal carers, for example if the ICECAP-O and the 
CarerQoL were used, respectively, it would be necessary to 
perform multiple-criteria decision analysis, which may be 
more costly and time consuming.
Before the ICECAP-O can be used as a well-being meas-
ure in economic evaluations of care interventions, it needs to 
be validated in relevant populations. Validation is performed 
to assess the extent to which a measure evaluates what it sets 
out to represent. The most frequently used validity tests for 
health status measures in the literature are construct validity 
tests. These examine the extent to which the measure indeed 
captures the concept it intends to measure [14]. Construct 
validity consists of both convergent and discriminant valid-
ity. Convergent validity refers to the extent to which a meas-
ure correlates with related concepts [14], while discriminant 
validity refers to the extent to which relevant differences in 
(sub-) groups are adequately reflected by the measure [9].
So far, the ICECAP-O has been validated for various 
populations such as older people in England [12, 15–18], 
psycho-geriatric older people in nursing homes in the Neth-
erlands [19], post-hospitalized older people in the Nether-
lands [20] and older people with dementia in Germany [5], 
mostly with favourable results. In these studies, sample sizes 
typically have been relatively small and taken from only one 
country. To date, to our knowledge, no study has validated 
the ICECAP-O as a well-being measure in informal carers.
In this study, we therefore add to the literature in a num-
ber of ways. This is the first study to validate the ICECAP-
O in a sample of informal carers, using a rich dataset. We 
use data from a relatively large sample of carers obtained 
in eight European countries in the context of the Actifcare 
project [21], which aims to analyse the pathways to care for 
people with dementia and their families. This paper therefore 
considers the construct validity of the ICECAP-O in a size-
able international population of informal carers for people 
with dementia. Furthermore, validating the ICECAP-O in 
this kind of population allows those performing economic 
evaluations to consider the ICECAP-O when measuring 
carer well-being.
Methods
Data were collected in eight European countries: Germany, 
Ireland, Italy, the Netherlands, Norway, Portugal, Sweden 
and the UK. Care receivers adhering to the specified crite-
ria ("Appendix 1") and their informal carers were invited 
to complete the questionnaires, available in seven differ-
ent languages. For all measures, including the ICECAP-O, 
nationally validated versions were used, or, if not available, 
the measure was translated, back translated and pilot tested 
following a translation protocol [21–23]. The data collec-
tion consisted of different parts. People with dementia and 
carers were interviewed by trained interviewers about their 
socio-demographic characteristics and the comorbidities and 
health care resource use of the former. Carers completed 
questionnaires covering a variety of outcome measures 
and were interviewed about the caregiving situation, their 
resource use, and the person with dementia’s health. Finally, 
the interviewer completed questionnaires about the health, 
quality of life and care needs of the person with dementia 
[21].
Demographic characteristics included age, gender, nation-
ality, ethnicity, marital status, level of education and state 
of employment. Before listing the health and well-being 
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measures used in our analyses, it is worth describing the 
ICECAP-O in further detail. As mentioned above, the ICE-
CAP-O is a general capability well-being measure, consist-
ing of five dimensions: attachment, security, role, enjoyment 
and control. These dimensions are sometimes described in 
a little more detail as ‘love and friendship’, ‘thinking about 
the future’, ‘doing things that make you feel valued’, ‘enjoy-
ment and pleasure’ and ‘independence’. The ICECAP-O and 
has four answering levels per domain which are no capabil-
ity, a little capability, a lot of capability and full capability. 
The ICECAP-O provides us with separate scores for each 
domain, meaning there are 1024 different possible ‘capa-
bility states’. By attaching the designated utilities to each 
attribute, we are provided with a final ICECAP-O tariff score 
with a range between zero (no capability) and one (full capa-
bility) [15].
There are health and well-being measures used in our 
analysis to test the validity of the ICECAP-O. The first 
measures are those answered by the carer, about the carer 
and their environment. These are CarerQol [9], EQ-5D-5L 
[24], Positive Affect Index (PAI) [25], Perseverance Time 
(PT) [26] and the Lubben Social Network Scale (LSNS) 
[27]. The next measures are those answered by the carer and/
or an interviewer as a proxy about the person with dementia. 
These are Clinical Dementia Rating (CDR) [28], DemQoL-
U [29, 30] (proxy-rated), Quality of Life in Alzheimer’s 
disease (QoL-AD) [31], Resource Utilization in Demen-
tia (RUD) [32], and finally a subset of questions regarding 
unmet need from the Camberwell Assessment of Need for 
the Elderly (CANE) [33]. These measures are discussed and 
referenced in Table 1. Here it is important to note that when 
referring to ‘CANE Unmet Need’ we are referring to a meas-
ure taken from the CANE instrument, which in this case was 
collected by an interviewer talking with the carer and person 
with dementia. In the measure, we sum the number of times 
‘unmet need’ is chosen out of the 24 questions asked. Sum-
mary statistics of all continuous variables used are shown 
in "Appendix 2".
Data analysis
To test whether the ICECAP-O is a valid measure of capa-
bility well-being, two main sections of analysis were per-
formed: convergent validity and discriminant validity. A 
priori expected correlations and relationships between the 
ICECAP-O and other variables from the questionnaires, dis-
cussed below, were drawn from previous literature, if avail-
able. In the analyses, correlation strength levels were taken 
from Cohen’s Set Correlation and Contingency Tables [34]. 
Correlations are considered strong if the coefficient is above 
0.5, moderate if the coefficient is between 0.3 and 0.5, and 
weak if the coefficient is below 0.3. A p value of 0.05 was 
taken to signify statistical significance.
Convergent validity
To test convergent validity, Spearman correlation coeffi-
cients of the tariff scores and dimensions of the ICECAP-O 
were compared against the EQ-5D-5L results (utility tariff, 
health problems index, and VAS) [35], CarerQol-7D tariff 
scores and CarerQol-VAS scores, respectively. It was antici-
pated that there would be a moderate positive correlation 
between the ICECAP-O scores and the EQ-5D-5L utility 
tariff scores and VAS scores of carers, a moderate nega-
tive correlation between the ICECAP-O scores and the EQ-
5D-5L health problems index of carers, and a strong positive 
correlation between the ICECAP-O and the CarerQol scores.
Discriminant validity
For discriminant validity, sub-groups were defined based 
on characteristics that previously were shown to be related 
to informal carer outcomes. For measures that have no pre-
defined cut-off points for high or low, in this case the EQ-
5D-5L tariff and VAS scores, the cut-off points between sub-
groups were primarily based on a face valid classification in 
relatively similar group sizes. Education was split unto three 
sub-groups based on primary school only (low), up to high-
school education (medium), and higher education (high).
Student’s t tests (for two sub-groups) or ANOVA (for 
more than two sub-groups) were performed to identify sig-
nificant differences in ICECAP-O scores. Then, a multivari-
ate regression model was estimated for the ICECAP-O tariff 
scores using all variables in which the ICECAP-O could 
discriminate at a P value of 0.1 or less, to gain insight into 
the magnitude and significance of the variables that were 
associated with the ICECAP-O scores. There are exceptions 
to this exclusion rule: the variables age, gender, education, 
relationship between the carer and person with dementia, 
and carer daily hours. We include age, gender, education, 
and the type of relationship because these are basic demo-
graphic factors. It was pre-defined by the authors that carer 
daily hours would be included in the multivariate regression 
as it is a key variable in the care giving context. A second 
model was estimated including country dummies, to account 
for country-level effects. In this regression, Germany was 
used as the reference country as it had the lowest mean ICE-
CAP-O score among carers.
Several hypotheses were generated regarding carer, 
care receiver and caregiving context variables and their 
relationship with the ICECAP-O. It is important to note 
that this literature did not necessarily refer to informal 
caregivers, or carers of people with dementia. Regarding 
carer variables, employed carers were expected to have a 
significantly higher ICECAP-O score than those unem-
ployed [36], carers with higher health status (i.e. a higher 
EQ-5D-5L score) were expected to have significantly 
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higher ICECAP-O scores than those with lower health 
status [37], and carers with a higher PAI score were 
expected to have a significantly higher ICECAP-O score 
than those with a lower PAI score [38]. Furthermore, 
there was insufficient evidence to form a hypothesis on 
the effect of carer age on the ICECAP-O [20, 39]. There 
was no expectation for the ICECAP-O to score differently 
for different levels of carer education [20]. Regarding 
care receiver variables, carers for a person with demen-
tia with a higher health status (i.e. a higher EQ-5D-5L, 
DemQoL-U and QoL-AD score, or a lower CDR score) 
were expected to have a significantly higher ICECAP-O 
score than carers for persons with lower health status. 
Finally, regarding caregiving context variables, carers 
with a low care burden (i.e. fewer daily care hours, lower 
CANE unmet needs in the person with dementia, higher 
PT and/or higher RUD scores) were expected to have a 
significantly higher ICECAP-O score than those with a 
higher care burden [40], and carers with a higher LSNS 
score were expected to have a significantly higher ICE-
CAP-O score than those with a lower LSNS score [41].
All tariff scores (for ICECAP-O, EQ-5D-5L and Car-
erQol-7D) were calculated using UK value sets because 
of both their availability and the need for consistency. 
The proxy ratings of the informal carers were used for 
the EQ-5D-5L, QoL-AD and DemQoL-U of people with 
dementia. All analyses were performed in STATA 14.
Results
Study sample
A total of 451 informal carers and home-dwelling people 
with mild to moderate dementia completed the question-
naires and were included in the analysis. The people with 
dementia were selected for this study based on their prob-
ability of needing formal care within 1 year. Table 2 pre-
sents sample characteristics of informal carers, the people 
with dementia (or care receivers) and the caregiving situ-
ation. The mean age of informal carers was 66.4 years 
old. Most of the carers were female and 28% of the carers 
were employed. The mean age of the care receivers was 
77.7 years and approximately half of them were female.
Figure 1 shows the scores of informal carers on the 
different dimensions of the ICECAP-O. The mean ICE-
CAP-O tariff score of the informal carers was 0.78, with 
standard deviation 0.16. The minimum tariff score in the 
sample was 0 while the maximum score was 1. The mean 
ICECAP tariff scores varied per country, as displayed in 
Table 3.
Table 2  Sample characteristics and bivariate results
Demographic % Mean 
ICECAP-O 
tariff
P value
Carer
 Age
  < 66 years 42.3 0.80 0.01*
  ≥ 66 years 57.7 0.77
Gender
 Male 33.6 0.79 0.48
 Female 66.4 0.78
Years of education
 Low (< 8) 19.6 0.73 0.37
 Medium (≥ 8 & ≤ 16) 60.8 0.79
 High (> 16) 19.6 0.80
Occupation
 Employed 28.1 0.84 0.02*
 Not employed 71.9 0.76
Positive affect index
 Low (≤ 21) 51.3 0.75 < 0.01*
 High (> 21) 47.7 0.82
CANE unmet need (0 to 24)
 Low care need (< 2) 55.7 0.79 < 0.01*
 Medium care need (≥ 2 and ≤ 5) 34.6 0.80
 High care need (> 5) 9.7 0.69
Perseverance time
 < 2 years 29.7 0.72 < 0.01*
 ≥ 2 years 70.3 0.81
LSNS
 Danger social isolation 24.5 0.71 < 0.01*
 No danger social isolation 75.5 0.81
Care receiver
 Age
  < 80 years 51.9 0.78 0.08*
  ≥ 80 years 48.1 0.79
Gender
 Male 45.5 0.75 0.62
 Female 54.5 0.81
EQ-5D-5L utility tariff score
 Low (< 0.68) 32.8 0.73 0.01*
 Medium (≥ 0.68 and < 0.8) 33.7 0.80
 High (≥ 0.8) 33.5 0.81
EQ-5D-5L health problems index
 Low (< 6) 62.8 0.81 0.04*
 Medium (≥ 6 and ≤ 12) 32.0 0.74
 High (> 12) 0.05 0.50
EQ-VAS
 Low (< 50) 38.4 0.77 < 0.11
 Medium (≥ 50 and ≤ 75) 36.2 0.78
 High (> 75) 25.4 0.80
QoL-AD
 Low (≤ 31.5) 47.6 0.73 < 0.01*
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Convergent validity
The Spearman’s correlation coefficients are presented in 
Table 4. There was a moderate positive correlation between 
the ICECAP-O tariff scores and the EQ-5D-5L utility tariff 
and EQ-VAS scores, a moderate negative correlation with 
the EQ-5D-5L health problems index, and a strong posi-
tive correlation with the CarerQol tariff and CarerQol-VAS 
scores.
Looking at the dimensions of the ICECAP-O in Table 4, 
it is clear that the other measures hold the strongest corre-
lations with the Security, Role and Enjoyment dimensions 
of the ICECAP-O. Country-specific correlations are pro-
vided in "Appendix 3". Overall country-specific correla-
tions matched those of the aggregate results, with Sweden 
being somewhat of an exception. In the correlation results 
for Sweden, the EQ-5D-5L utility tariff score and health 
problems index were uncorrelated with the ICECAP-O.
Discriminant validity
Bivariate results regarding discriminant validity are shown 
in Table 2. The ICECAP-O significantly discriminated 
between old and young informal carers, between those 
who were employed and unemployed, between carers with 
low and high PAI, between carers who were and were not 
in danger of social isolation (LSNS) and carers who felt 
they could and could not continue caregiving for 2 years or 
more (PT). The ICECAP-O mean scores all differed in the 
expected direction. The ICECAP-O did not discriminate 
between carers who had daily care hours of less than 4 h 
or 4 h and over.
The ICECAP-O discriminated between carers of people 
who were 80 years of age or over, or below 80 years of 
age, between carers of those who received some home care 
services versus those who received no home care services, 
carers of people with dementia with high and low numbers 
of unmet needs (CANE), and carers for people with demen-
tia who had or had not spent time in hospital in the past 
month (RUD). A significant difference in ICECAP-O scores 
between carers of care receivers with high, medium and 
low levels of both the EQ-5D-5L tariff score and the EQ-
5D-5L health problems index was observed. The ICECAP-O 
mean score was lower for carers of those with a lower QoL-
AD or a higher CDR, and for carers of those with a lower 
DemQoL-U score.
*P value of 0.1 or less
Table 2  (continued)
Demographic % Mean 
ICECAP-O 
tariff
P value
 High (> 31.5) 52.4 0.82
DemQoL-U
 < 0.9 74.9 0.77 0.08*
 ≥ 0.9 25.1 0.82
CDR
 ≤ 1 80.4 0.79 0.01*
 > 1 19.6 0.74
RUD (per month)
 Some hospital days 3.0 0.74 < 0.01*
 No hospital days 97.0 0.78
 Some practitioner visits 72.1 0.79 0.62
 No practitioner visits 27.9 0.78
 Some home care services 72.0 0.79 0.08*
 No home care services 27.0 0.78
Caregiving situation
 Relationship with person with dementia
  Spouse/partner 63.9 0.76 0.22
  Son/daughter (in-law) 31.9 0.82
  Other 4.2 0.86
Daily care hours
 Low (< 4 h) 48.5 0.80 0.28
 High (≥ 4 h) 51.5 0.77
Fig. 1  ICECAP-O response of informal carers
Table 3  ICECAP-O values per country, ranked by mean tariff*
*Differences are statistically significant from each other. P 
value < 0.01
Country ICECAP-O tariff
Germany 0.732
Portugal 0.753
United Kingdom 0.769
Italy 0.772
Ireland 0.781
The Netherlands 0.809
Sweden 0.816
Norway 0.834
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Multivariate analysis
The multivariate regression results are shown in Table 5. 
Due to missing data, only 389 observations were included 
in this analysis.
Several results can be derived from the multivariate 
regression. The age of the person with dementia, the rela-
tionship with the person with dementia, CDR, social isola-
tion (LSNS) of the carer, the Positive Affect Index of the 
carer, and Perseverance Time all had a significant rela-
tionship with the ICECAP-O tariff score. Age of the per-
son with dementia had a non-linear relationship with the 
carer ICECAP-O score, suggesting that when people with 
dementia reach roughly age 79 carer ICECAP-O scores 
stop increasing and start decreasing. Spouses or partners 
who care for the person with dementia had a significantly 
worse well-being than carers with other relationships with 
the recipient of care. A higher EQ-5D-5L health problems 
index had a significant negative relation with carer well-
being. A higher CDR for the person with dementia score 
had a significant negative relation with carer well-being. 
A higher LSNS score had a significant positive relation 
with carer well-being, as did a higher PT score, while a 
higher PAI score had a significant positive relation with 
carer well-being. This can be summarized to mean that a 
lower severity of dementia and fewer health problems in 
the person with dementia, a better relationship with the 
person with dementia, and more perseverance time and 
less loneliness of the carer were associated with better 
well-being in the latter. The regression analysis in which 
countries were included shows that Norway has higher 
levels of carer well-being than the other countries in the 
sample.
Discussion
The aim of this paper was to determine the validity of 
the ICECAP-O in a relatively large, eight-country popu-
lation sample of informal carers for people living with 
dementia. Validation was performed using convergent and 
discriminant validity tests, followed by multivariate analy-
sis. As hypothesized, there were significant moderate-to-
strong correlations in the expected directions between the 
ICECAP-O scores and carers’ EQ-5D-5L utility tariff score 
and health problems index, EQ-VAS scores, as well as the 
CarerQol-7D and the CarerQol-VAS scores. The multi-
variate regressions showed that the age of the person with 
dementia, the EQ-5D-5L health index of the person with 
dementia, carer–patient relationship, care recipient CDR, 
carer LSNS Score, the carer PAI score, and Perseverance 
Time all had a significant relation with the carer ICECAP-
O score. The fact that age of the person with dementia had 
a non-linear relationship with the carer’s ICECAP-O score 
may be explained by older people with dementia having 
more health and behavioural problems that were not cap-
tured in the multivariate regression. The reason for age 
of the person with the dementia being correlated with an 
increase in the ICECAP-O until age 79 is still a somewhat 
surprising result, perhaps explained by younger people 
wanting to take part in more activities or work than their 
older counterparts. Somewhat surprisingly, the ICECAP-O 
did not have a significant relationship with the number of 
daily care hours, even though it was assumed these would 
have an impact on carer well-being. This may be due to the 
selection of the sample as only people with mild to moder-
ate dementia were included. The results also showed that 
living in certain countries may be of importance for the 
carer ICECAP-O scores.
Even though we presented the first validation of the 
ICECAP-O instrument in a sample of informal carers, our 
results were quite comparable to results from previous ICE-
CAP-O validation studies [5, 12, 16, 19, 20]. While many 
addressed the specific dimensions of the ICECAP-O rather 
than the ICECAP-O tariff scores, several of the results 
found in our study were similar to those of previous studies. 
Almost all studies found that the ICECAP-O could discrim-
inate effectively between groups of different ages [5, 12, 
16, 20]. Additionally, all studies found moderate-to-strong 
convergent validity between the ICECAP-O and health 
(quite frequently using the EQ-5D as measure) although not 
necessarily for every dimension of both measures. Makai 
Table 4  Spearman correlations
Instrument ICECAP-O tariff P value ICECAP-O domains
Attachment Security Role Enjoyment Control
EQ-5D-5L utility tariff score 0.46 < 0.01 0.22 0.42 0.39 0.41 0.26
EQ-5D-5L health problems index − 0.45 < 0.01 − 0.21 − 0.41 − 0.38 − 0.39 − 0.28
EQ-VAS 0.45 < 0.01 0.25 0.34 0.33 0.42 0.19
CarerQol tariff 0.53 < 0.01 0.38 0.42 0.44 0.46 0.27
CarerQol-VAS 0.54 < 0.01 0.43 0.41 0.46 0.51 0.18
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Table 5  Multivariate regression coefficients, confidence intervals and P values
ICECAP-O tariff ICECAP-O tariff (including countries)
Carer
Age (years) 0.003 (− 0.005, 0.012) 0.002 (− 0.007, 0.010)
0.47 0.73
Age2 − 0.00001 (− 0.0001, 0.0001) − 0.000001 (− 0.00007, 0.00007)
0.84 0.97
Gender (Female = 1 Male = 0) − 0.025 (− 0.063, 0.012) − 0.017 (− 0.055, 0.020)
0.19 0.37
Education (years) 0.003 (− 0.001, 0.006) 0.001 (− 0.002, 0.005)
0.13 0.42
Employed (employed = 1 unemployed = 0) 0.024 (− 0.019, 0.066) 0.018 (− 0.025, 0.061)
0.28 0.42
PAI (range 6 to 30) 0.009 (0.006, 0.012) 0.009 (0.006, 0.012)
< 0.01* < 0.01*
Care recipient
Age (years) 0.029 (0.006, 0.052) 0.031 (0.008, 0.054)
0.02* 0.01*
Age2 − 0.0001 (− 0.0003, − 0.00003) − 0.0002 (− 0.0004, − 0.00004)
0.02* 0.01*
Gender (Female = 1 Male = 0) 0.010 (− 0.028, 0.048) 0.015 (− 0.024, 0.053)
0.62 0.46
CDR (Range 0 to 5) − 0.041 (− 0.075, − 0.006) − 0.039 (− 0.073, − 0.005)
0.02* 0.02*
EQ-5D-5L health problems index − 0.005 (− 0.010, − 0.0004) − 0.005 (− 0.010, − 0.0003)
0.03* 0.04*
Caregiving context
Spouse/partner (spouse or partner = 1 not spouse or 
partner = 0)
− 0.115 (− 0.174, − 0.056) − 0.107 (− 0.165, − 0.048)
< 0.01* < 0.01*
Carer daily hours (hours) 0.002(− 0.0004, 0.005) 0.002 (− 0.0003, 0.0002)
0.09 0.234
Unmet needs (CANE) − 0.003 (− 0.010, 0.004) − 0.004 (− 0.012, 0.004)
0.42 0.32
DemQol-U 0.00821 (− 0.123, 0.139) 0.008 (− 0.124, 0.139)
0.90 0.91
Perseverance time (range 0 to 6) 0.045 (0.006, 0.012) 0.047 (0.016, 0.078)
0.01* < 0.01*
Days in hospital − 0.002 (− 0.011, 0.006) − 0.002 (− 0.010, 0.007)
0.61 0.68
Total home care services − 0.0001 (− 0.0004, 0.0002) − 0.00006 (− 0.0004, 0.0003)
0.49 0.72
LSNS (range 0 to 36) 0.005 (0.003, 0.009) 0.005 (0.003, 0.008)
< 0.01* < 0.01*
Ireland 0.003 (− 0.069, 0.074)
0.94
Italy 0.0004 (− 0.067, 0.068)
0.99
The Netherlands 0.064 (− 0.003, 0.131)
0.06
Norway 0.073 (0.008, 0.139)
0.03*
Quality of Life Research 
1 3
et al. [20] also found that the ICECAP-O could discriminate 
between older people who had more or fewer opportunities 
for social interaction, which is in line with the significance 
of the LSNS score in our analysis. Most previous validation 
studies conclude that the ICECAP-O may be a promising 
patient outcome measure in economic evaluations, although 
it may not completely cover physical health [18]. Based 
on the results of the above analysis, this paper comes to 
the same conclusion for the validity of the ICECAP-O in 
carers (of persons with dementia). An interesting finding is 
that in Sweden the ICECAP-O was not correlated with the 
EQ-5D-5L utility tariff score and health problems index. 
One reason for this may be that in our sample, the lowest 
EQ-5D-5L utility tariff score in Sweden is approximately 
0.37, which is far higher than the lowest score from the full 
sample (− 0.1).
The main strength of this study is that it is the first to 
validate the ICECAP-O in carers: in a sample both large in 
size and country variety. While several validation studies 
of the ICECAP-O have been executed, they all used rela-
tively small sample sizes and only focused on one country. 
The eight-country nature of this sample allowed a more 
comprehensive overview of the ICECAP-O’s validity in 
Europe (in carers). Another strength is that extensive data 
were provided on both carers and care receivers. None of the 
previous studies looked at convergent validity between the 
ICECAP-O and the CarerQol, CANE, RUD, PAI, QoL-AD 
and Perseverance Time. Moreover, this study was the first 
to validate the ICECAP-O in carers.
Some limitations of our study need to be mentioned 
as well. First is the lack of variation within the sample. 
Large percentages of both carers and care receivers were 
relatively healthy and most carers seemed to experience a 
relatively low care burden, which may be the result from 
selection bias as carers who experience a high care burden 
may be less likely to participate in the study. Therefore, 
a detailed analysis of validity of the ICECAP-O in those 
carers who are less healthy or feel higher care burden is 
not possible here. Second, carer proxy scores were used for 
some of the outcome measures for people with dementia 
(i.e. EQ-5D-5L, QoL-AD and DemQoL-U). The correla-
tion of ICECAP-O scores with the harder to observe vari-
ables for persons with dementia (such as the DemQoL-U 
items) may be less reliable than those with more easily 
observed variables (such as the EQ-5D-5L items). In addi-
tion, due to the neurodegenerative nature of dementia and 
the stress experienced by carers, proxies may give more 
negative answers regarding care receivers’ health and 
well-being [42]. While this most likely does not affect our 
regression results, as from the measures of health of per-
sons with dementia only CDR was used, it is worth bearing 
in mind for future studies. Another limitation is the use 
of UK value sets for both the ICECAP-O and EQ-5D-5L-
related measures. This was done for consistency, as value 
sets were not available for all countries in the sample; how-
ever, it may be partially responsible for Sweden-specific 
EQ-5D-5L results being uncorrelated with the ICECAP-
O. Finally, we used the ICECAP-O in the complete sam-
ple of carers. However, as can be derived from Table 2, 
nearly half of carers were younger than 65. The ICECAP-O 
(Older) was designed to capture the capability well-being 
of people age 65 and over. For people aged under 65, the 
ICECAP-A (Adults) [6]—which covers the five capability 
well-being dimensions attachment, stability, achievement, 
enjoyment and autonomy—would in principle be more 
suitable. This was not feasible in the current study. It is 
unclear how accurately the ICECAP-O measures the well-
being of people aged under 65.
Germany is the reference country
Confidence intervals in bold indicate a significant effect
*P value of 0.05 or less
Table 5  (continued)
ICECAP-O tariff ICECAP-O tariff (including countries)
Portugal − 0.030 (− 0.097, 0.037)
0.38
Sweden 0.043 (− 0.026, 0.112)
0.22
United Kingdom 0.013 (− 0.051, 0.076)
0.70
Constant − 0.707 (− 0.123, 0.242) − 0.722 (− 1.656, 0.212)
0.14 0.13
N 389 389
R2 0.3359 0.3359
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It has been shown in previous validation studies that 
the ICECAP-O is a worthy contender as a patient outcome 
measure in economic evaluations regarding care of the older 
people, due to its broad, well-being-focused nature. In this 
study, the ICECAP-O has shown good convergent and dis-
criminant validity as a well-being outcome measure in carers 
of people with dementia. These findings suggest that the 
ICECAP-O potentially is a relevant and useful measure for 
economic evaluation in samples of elderly informal carers, 
especially when considering interventions that have impacts 
‘beyond health’. If it is used in both carers and care receivers, 
this allows comparisons of outcomes across interventions 
and aggregation of outcomes within interventions. Before 
being able to recommend this, a number of important issues 
need to be resolved. First, the ICECAP-O needs to be further 
validated as an outcome measure among people with demen-
tia and their carers. This would include linguistic validation 
of translations of the ICECAP-O, currently being analysed 
in Germany and Portugal as part of the Actifcare project 
[21]. It would be beneficial to conduct linguistic validations 
in other countries where psychometric validations have been 
conducted [48]. Second, future studies need to confirm our 
results and expand on them, to increase the evidence of the 
validity of the ICECAP-O. Third, a choice needs to be made 
whether the use of the generic ICECAP-O (which is aimed 
at older people) is to be preferred over the use of more carer-
specific well-being measures, such as the CarerQol. While 
the results of the latter may be less easily aggregated with, 
for example, ICECAP outcomes in patients, they may pro-
vide more precise estimates of care-related quality of life 
and more detailed information. Finally, while the CarerQoL 
is aimed at carers (regardless of age), the ICECAP measures 
would need to be tailored to age groups of carers, which 
raises questions of aggregation and comparison of ICECAP-
A and ICECAP-O scores.
Further research of the ICECAP-O in samples of infor-
mal carers for people with different chronic illnesses would 
also be useful. It would allow investigation into whether the 
ICECAP-O is also a valid measure and shows similar rela-
tionships to other outcomes in the context of diverse chronic 
illnesses. If the ICECAP-O is to be used as a well-being 
measure in economic evaluations, it would also be of interest 
to conduct further research into its sensitivity to change and 
Minimal Clinically Important Difference.
The ICECAP-O is a capability well-being measure that 
has been proven to be of use for economic evaluations of 
care of older people. This study adds that the ICECAP-O 
may be useful in economic evaluations of interventions con-
sidering elderly informal carers, where a broader measure of 
well-being is more relevant than a narrower health-related 
quality of life measure such as the EQ-5D-5L.
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Appendix 1
Inclusion and exclusion criteria
Inclusion criteria
• The patient has a diagnosis of dementia meeting DSM IV 
TR criteria following an assessment by a clinical profes-
sional.
• The person with dementia has a Clinical Dementia Rat-
ing indicating mild or moderate degree of dementia (i.e. 
scores 1 or 2) or scores 24 or less on the MMSE.
• The patient is not receiving regular assistance from a paid 
worker with personal care, on account of his/her demen-
tia, such as help with dressing/undressing; washing/
bathing/showering; toileting; feeding/drinking; taking 
medication. (Note: ‘regular’ is defined as at least once 
per week; ‘paid worker’ includes those paid by health and 
social care services and those paid direct by the person 
and his/her family).
• A professional judges that additional assistance with 
personal care is likely to be considered/required within 
1 year.
• The person with dementia has a carer who is able and 
willing to participate also and is in contact at least once 
per week. The carer does not have to be residing with 
the carer, they could be a relative, friend or neighbour in 
regular contact.
Exclusion criteria
• The person with dementia or their carer is not able to 
complete the assessments due to communication/lan-
guage/hearing/understanding/literacy problems that can-
not be compensated for.
• The person with dementia or their carer has a terminal 
condition or comorbidities (including long-standing 
severe mental illness) contributing to a significant level 
of disability.
• The person with dementia or their carer has a life-long 
learning disability or severe physical impairment that 
would prevent them from being able to complete the 
assessments.
• The person with dementia resides in a care home or nurs-
ing home or has been resident in a care home or nursing 
home (e.g. for respite) during the previous 6 months.
• The person with dementia has a diagnosis of alcohol-
related dementia or of Huntington’s disease.
Appendix 2
See Table 6.
Appendix 3
See Table 7.
Table 6  Summary statistics at baseline of continuous variables
Mean SD Min Max
Carer
 Age (years) 66.42 13.23 25 92
 Education (years) 11.91 4.42 0 24
 EQ-5D-5L utility tariff score 0.84 0.17 − 0.10 1
 EQ-5D-5L health problems index 2.90 2.86 0 15
 EQ-VAS 71.58 18.22 0 100
Care receiver
 Age (years) 77.77 7.83 47 98
 Education (years) 9.85 4.49 0 25
 EQ-5D-5L utility tariff score 0.71 0.21 − 0.11 1
 EQ-5D-5L health problems index 5.43 3.46 0 16
 EQ-VAS 61.13 19.77 0 100
 Qol-AD sum score 31.36 6.00 16 50
 DemQol-U tariff 0.82 0.11 0.46 0.99
Caregiving context
 Daily carer time (hours in a day) 6.33 5.96 0 23.23
 Number of unmet needs (CANE) 1.78 2.04 0 12
 Hospital days (RUD) last month 0.20 1.68 0 28
 Practitioner visits (RUD) last month 1.57 2.12 0 17
 Home service visits (RUD) last 
month
8.91 38.53 0 720
 LSNS total score 16.60 5.55 2 30
 CarerQol-7D utility tariff score 77.59 17.38 8.8 100
 CarerQol-VAS 6.34 1.97 0 10
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Table 7  Country-specific spearman correlation
Instrument ICECAP-O tariff P value ICECAP-O domains
Attachment Security Role Enjoyment Control
Germany
 EQ-5D- 5L utility tariff score 0.34 0.02 0.26 0.55 0.54 0.33 0.11
 EQ-5D-5L health  problems index − 0.30 0.03 − 0.21 − 0.49 − 0.51 − 0.30 − 0.09
 EQ-VAS 0.43 < 0.01 0.48 0.27 0.41 0.38 0.31
 CarerQol tariff 0.62 < 0.01 0.56 0.61 0.48 0.55 0.47
 CarerQol-VAS 0.65 < 0.01 0.70 0.46 0.51 0.51 0.50
Ireland
 EQ-5D-5L utility tariff score 0.64 < 0.01 0.35 0.59 0.48 0.46 0.54
 EQ-5D-5L health problems index − 0.68 < 0.01 − 0.36 − 0.59 − 0.44 − 0.45 − 0.58
 EQ-VAS 0.39 < 0.01 0.20 0.32 0.038 0.28 0.30
CarerQol tariff 0.76 < 0.01 0.61 0.57 0.68 0.63 0.62
 CarerQol-VAS 0.41 < 0.01 0.24 0.47 0.45 0.39 0.31
Italy
 EQ-5D-5L utility tariff score 0.56 < 0.01 0.34 0.37 0.39 0.56 0.48
 EQ-5D-5L health problems index − 0.56 < 0.01 − 0.40 − 0.36 − 0.45 − 0.54 − 0.47
 EQ-VAS 0.53 < 0.01 0.45 0.26 0.33 0.49 0.36
 CarerQol tariff 0.36 0.01 0.25 0.36 0.11 0.40 0.16
 CarerQol-VAS 0.34 0.01 0.31 0.14 0.39 0.35 0.15
The Netherlands
 EQ-5D-5L utility tariff score 0.51 < 0.01 0.11 0.47 0.40 0.49 0.30
 EQ-5D-5L health problems index − 0.48 < 0.01 − 0.07 − 0.43 − 0.38 − 0.45 − 0.31
 EQ-VAS 0.32 0.02 0.01 0.28 0.24 0.34 0.14
 CarerQol tariff 0.45 < 0.01 0.27 0.28 0.43 0.52 0.25
 CarerQol-VAS 0.51 < 0.01 0.32 0.34 0.46 0.51 0.16
Norway
 EQ-5D-5L utility tariff score 0.53 < 0.01 0.33 0.40 0.39 0.59 0.21
 EQ-5D-5L health problems index − 0.49 < 0.01 − 0.29 − 0.37 − 0.37 − 0.56 − 0.22
 EQ-VAS 0.47 < 0.01 0.25 0.24 0.37 0.51 0.31
 CarerQol tariff 0.47 < 0.01 0.40 0.22 0.33 0.48 -0.11
 CarerQol-VAS 0.54 < 0.01 0.40 0.26 0.38 0.61 0.12
Portugal
 EQ-5D-5L utility tariff score 0.61 < 0.01 0.25 0.51 0.54 0.48 0.32
 EQ-5D-5L health problems index − 0.66 < 0.01 − 0.23 − 0.55 − 0.55 − 0.51 − 0.34
 EQ-VAS 0.69 < 0.01 0.27 0.58 0.52 0.49 0.33
 CarerQol tariff 0.52 < 0.01 0.43 0.41 0.54 0.39 0.12
 CarerQol-VAS 0.63 < 0.01 0.45 0.38 0.64 0.57 0.23
Sweden
 EQ-5D-5L utility tariff score 0.21 0.14 0.05 0.31 0.10 0.12 0.14
 EQ-5D-5L health problems index − 0.17 0.25 − 0.04 − 0.29 − 0.05 − 0.09 − 0.12
 EQ-VAS 0.39 < 0.01 0.19 0.26 0.09 0.37 0.13
 CarerQol tariff 0.52 < 0.01 0.11 0.36 0.28 0.42 0.34
 CarerQol-VAS 0.49 < 0.01 0.35 0.47 0.35 0.44 0.11
United Kingdom
 EQ-5D-5L utility tariff score 0.36 < 0.01 0.17 0.31 0.43 0.34 0.24
 EQ-5D-5L health problems index − 0.36 < 0.01 − 0.18 − 0.30 − 0.43 − 0.31 − 0.25
 EQ-VAS 0.32 < 0.01 0.13 0.40 0.40 0.41 -0.06
 CarerQol tariff 0.48 < 0.01 0.47 0.49 0.54 0.34 0.19
 CarerQol-VAS 0.62 < 0.01 0.55 0.62 0.57 0.53 0.07
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